InTRODuCTIOn
Promotion (direct advertising such as ads on mass media and indirect advertising), price (special price offers and discounts) and product packaging are tobacco companies' key marketing strategies. 1 Because tobacco product marketing increases tobacco product use, 2 the Framework Convention on Tobacco Control directs the 181 ratifying countries to adopt comprehensive bans on all forms of tobacco marketing. 3 Many countries have banned tobacco marketing through most channels, although implementation challenges remain, especially for online channels. 4 Around the world, most countries have banned cigarette promotion in print and broadcast media. 5 In response, the tobacco industry has shifted its marketing efforts to the point of sale (POS), price and packaging. 6 As of 2016, Australia (AU), Canada (CA) and England (EN) have extended their cigarette advertising bans to POS, including cigarette displays, but they are still allowed in the USA. Price offers at the POS are allowed and common in the USA. In AU, price offers can be made using large price boards (1.5×1.5 m) at the POS, 7 whereas CA and EN ban price offers but allow the display of prices, using smaller price boards (29.7x42 cm) in the case of EN.
Countries have made different approaches to regulate nicotine vaping product (NVP) marketing. As shown in table 1, EN and USA have fewer restrictions on the marketing of NVPs compared with AU and CA. AU prohibits the marketing and sales of NVPs. CA had banned the marketing and sales of NVPs until April 2018, 8 9 although NVPs were widely available. 10 EN and USA allow sales of NVPs to adults both online and in retail shops, although NVP advertising cannot contain reducedrisk or cessation claims. EN banned cross-border or broadcast advertising and direct NVP advertising via emails and text messages, but allows local advertising (eg, POS) and ads on social media. 11 The USA has not banned NVP advertising in any channels.
Studies of adult smokers have found that patterns of self-reported cigarette advertising exposure generally reflect channel-specific advertising restrictions. [12] [13] [14] Exposure to any tobacco advertising was lower in European countries with more comprehensive tobacco advertising bans. 15 Between 2008 and 2011, exposure to price offers was associated with continued smoking among smokers in AU and the USA but not in CA and UK, but it is unknown whether smokers used the price offers. 16 17 To date, only one cross-section study (by Wadsworth and colleagues) has examined patterns of exposures to vaping product advertising, finding that between 2013 and 2015 the pattern generally reflected national policies. 18 This paper aims to extend Wadsworth et al's research by addressing the following research questions: RQ1 . Are the patterns of exposure to advertising for cigarettes and/or vaping products from specific channels related to each countries' regulations? As 
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in prior research, we expect that advertising exposures across all channels will be lower in AU and CA than in EN and US; however, we also expect that the 2016 ban of vaping ads through cross-border and broadcast channels in EN will result in lower exposure there than in US, which allows vaping ads through any channel. RQ2. How are the patterns of exposure to and use of price offers for cigarettes and vaping products related to countries' regulations around the product marketing? RQ3. How is exclusive and concurrent use of cigarettes and NVPs associated with patterns of exposure to cigarettes and vaping product advertising? We expect that use of a particular product will be associated with ad exposure, but we will advance research by comparing concurrent use with exclusive use of each product.
In particular, we expect that concurrent users will be more likely to report exposure to both cigarette and vaping ads compared to exclusive users.
METhODs sample
The Respondents of the ITC 4CV1 were recruited from two or more sources in each country via random-digit-dialling sampling frames, or web-based or addressed-based panels, or a combination of these frames. The ITC 4CV1 sample was designed to be representative of smokers and vapers in each country. A detailed description of sampling methods for each country can be found online. 19 20 Our sample consisted of 12 294 respondents (AU: n=1504; CA: n=3733; EN: n=4324; and USA: n=2733). Table 2 presents sample size and characteristics by country.
Measures
Exposure to cigarette adverting was assessed by asking: 'In the last 30 days, have you noticed cigarettes or roll-your-own (RYO) tobacco being advertised in any of the following places: "Inside shops/stores that sell cigarettes?" "Outside shops/ stores that sell cigarettes?" "On websites or social media sites?" "In email or text messages?"' Response options of 'Yes', 'No', 'Refused' and 'Don't know' were recoded, with 'Don't know' response coded as 'No' and 'Refused' taken as missing (same for exposure to vaping product advertising). Responses for the first two items were combined as a dichotomous variable to indicate any exposure to cigarette advertising at the POS (same for exposure to vaping product advertising), with exposure at any of the places inside or outside shops being taken as 'Yes'. Exposure to vaping product advertising was assessed by first asking: 'Have you ever used an e-cigarette or vaping device, even one time?' with response options of 'Yes', 'No', 'I have never heard of e-cigarettes/vaping devices.' Those who had never heard of e-cigarettes were coded as no exposure. Those who had heard of e-cigarettes were asked: 'In the last 30 days, have you noticed e-cigarettes, vaping devices or e-liquid being advertised in any of the following places: "Inside shops/stores that sell cigarettes?" "Outside shops/stores that sell e-cigarettes/vaping equipment?" "On websites or social media sites?" "In e-mail or text messages?"' Respondents could answer 'Yes', 'No', 'Refused' and 'Don't know'.
Exposure to both cigarette and vaping product advertising was assessed by combining the measures of cigarette advertising exposure and vaping product advertising exposure. Those who reported exposures to both cigarette advertising and vaping product advertising were coded as 'Yes'. Those who reported exposure to only cigarette advertising, only vaping product advertising or neither of the two products were coded as 'No'.
Exposure to price offers for cigarettes was assessed by asking: 'In the last 30 days, have you noticed any special price offers, Exposure to price offers for vaping products was assessed by asking: 'In the last 30 days, have you noticed any special price offers, such as discounts or coupons, for e-cigarettes/ vaping devices or e-liquid?' with response options of 'Yes, and purchased as a result', 'Yes, but not purchased', 'No', 'Refused' and 'Don't know'. The variable was dichotomised by combining the 'Yes' categories. 'No' and 'Don't know' were also combined, and 'Refused' was coded as missing.
Use of price offers for vaping products. Those who indicated that they noticed special price for vaping products and purchased as a result were coded as 'Yes'. Those who answered 'Yes, but not purchased', 'No' and 'Don't know' to the question asked about exposure to special price offers for vaping products were coded as 'No'.
Respondent type. Depending on respondents' smoking and vaping status, we categorised them into four types: exclusive smokers, concurrent users (ie, both vape and smoke at least monthly), exclusive vapers and former smokers. To assess smoking status, respondents were asked: 'How often, if at all, do you currently smoke ordinary cigarettes (either factory-made (FM)/packet or roll-your-own)?' Response options were 'Daily', 'Less than daily, but at least once a week', 'Less than weekly, but at least once a month', 'Less than monthly, but occasionally' and 'Not at all'. To assess vaping status, respondents were first asked: 'Have you ever used an e-cigarette or vaping device, even one time?', with response options of 'Yes', 'No', 'I have never heard of e-cigarettes/vaping devices', 'Refused' and 'Don't know'. Those who answered 'Yes' were asked: 'How often, if at all, do you currently use e-cigarettes/ vaping devices (ie, vape)?' Response options were 'Daily', 'Less than daily, but at least once a week', 'Less than weekly, but at least once a month', 'Less than monthly, but occasionally', and 'Not at all'. Those who were current smokers (who did not answer 'Not at all' to the question about current cigarette smoking status) but were not current vapers (who answered 'Less than monthly, but occasionally' or 'Not at all' to the question about current vaping status) were treated as 'exclusive smokers'. Those who were current users of both cigarettes and vaping products were categorised as 'concurrent users'. Those who were current vapers but were not current smokers were categorised as 'exclusive vapers'. Those who were not current smokers were asked whether they had smoked 100 or more cigarettes over their lifetime, and if so, they were treated as 'former smokers' if they were not current vapers.
Covariates. (technical, trade school, community college, some university but no degree in AU, CA and USA, or training college below degree level or some university but no degree in EN), high (completed university or postgraduate studies)) and annual household income (low (<US$30 000 in AU, CA and USA or ≤£15 000 in EN)), moderate (between US$30 000 and US$59 999 in AU, between US$30 000 and US$44 999 in CA and USA, and between £15 001 and £30 000 in EN), high (≥US$60 000 in AU, US$45 000 in CA and USA, and £30 001 in EN)).
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Analysis
Variables were assessed for differences among countries using chi-square tests. For each country, prevalence estimates for exposure to and use of cigarette and vaping product marketing were estimated. Logistic regression models that pooled data for all countries were used to assess cross-country difference and correlates of exposure to and use of cigarette and vaping product marketing, adjusting for all covariates. The estimated coefficients were compared between pairs of countries using Wald tests, adjusting for multiple comparisons using the Bonferroni method to control for type 1 error. We conducted four sensitivity analyses to assess potential bias due to misclassification. Models were re-estimated after excluding: (1) respondents who had never heard of vaping products (0.7% of sample), (2) respondents who reported 'don't know' when asked about their ad exposure (2.8%-4.3% of sample, depending on the outcome) and (3) respondents who had not noticed price offers (80.0% of sample for cigarettes; 34.3% of sample for vaping products). Finally, we estimated prevalence estimates for exposure to advertising of both cigarettes and vaping products, as well as the cross-country difference and correlates, which are reported in online supplementary table 1 . Results of the analyses were not meaningfully different from the results reported in the main text, except for the third analysis results (see online supplementary table 2). Each analysis was conducted using Stata V.13.0 and was adjusted for sampling weights designed to make the sample representative of the general population of tobacco users in each country in terms of demographic characteristics (eg, age, sex and geographic region).
REsulTs
Reported exposure to cigarette advertising by country
The prevalence of cigarette advertising exposure at POS (table 3) was highest in the USA (52.1%), followed by CA (18.5%), EN (13.6%) and AU (10.5%). The prevalence of cigarette advertising 
and AU (2.7%). The prevalence of cigarette advertising exposure in email or texts (table 4) was also highest in the USA (7.6%), followed by EN (3.3%) and CA (3.2%) and then AU (1.5%).
Reported exposure to vaping product advertising by country
The prevalence of vaping product advertising exposure at POS was highest in EN (49.3%), followed by USA (45.9%), then CA (32.5%) and lowest in AU (6.4%); exposure rates did not differ significantly between EN and USA (table 3). Exposure to vaping product advertising on websites or social media was highest in EN (18.4%), followed by CA (15.1%), then USA (12.1%) and finally AU (5.0%); the prevalence did not significantly differ between CA and USA (table 4). Exposure to vaping product advertising in email or texts in EN (9.9%) and USA (7.5%) was higher than in AU (3.1%) and CA (3.9%).
Reported exposure to both cigarette and vaping product advertising by country
The prevalence of exposure to both cigarette and vaping product advertising at POS was highest in the USA (36.5%), followed by CA (11.7%) and EN (9.5%), not significantly different, and then AU (3.3%). Exposure to both cigarette and vaping product advertising on websites or social media and emails or texts was low overall across countries, with the exposure rates ranging from 0.5% (emails or texts in AU) to 5.9% (websites or social media in USA).
Reported exposure to and use of price offers for cigarettes
Exposure to cigarette price offers (table 5) was highest in USA (34.0%), followed by AU (8.2%), CA (7.8%) and EN (3.6%). The prevalence of use of cigarette price offers was also highest in USA (17.8%), followed by AU (5.3%), CA (2.4%) and EN (1.5%). Among those who were exposed to price offers for cigarettes, the prevalence of using the offers was highest in AU (64.9%, significantly higher than 52.3% in USA, AOR=2.2, p=0.017) and lowest in CA (31.0%, AOR=0.5, p<0.001; online supplementary table 2).
Reported exposure to and use of price offers for vaping products
Exposure to price offers for vaping products (table 5) was highest in USA (42.3%), followed by EN (31.5%), AU (29.1%) and CA (25.9%). The prevalence of use of price offers for vaping products was highest in USA (21.7%), followed by EN (10.3%), CA (7.8%) and AU (7.4%). Among those who were exposed to price offers for vaping products, the use of the price offers was significantly lower in CA (30.1%) and EN (32.7%) than in USA (51.2%) (AOR=0.4, 0.4; p<0.001, p=0.001, respectively; online supplementary table 2).
Correlates of cigarette marketing exposure and use
Compared with exclusive smokers, concurrent users were more likely to report cigarette advertising exposure in any channel (p<0.001; tables 3 and 4) and to report exposure to price offers for cigarettes (p=0.025; table 5), but use of the offers did not differ between exclusive smokers and concurrent users (table 5).
Correlates of exposure to vaping product ads
Exclusive vapers were more likely than exclusive smokers to report exposure to vaping product advertising in any channel (p<0.01, p<0.001; tables 3 and 4).
Correlates of exposure to both cigarette and vaping product ads
Compared with exclusive smokers, concurrent users were more likely to report exposure to both cigarette and vaping product marketing in any channel (p<0.001; online supplementary table 1).
DIsCussIOn
As expected, our study found higher cigarette advertising exposure across all the channels we studied in the USA compared with AU, CA and EN where stricter regulations prohibit the cigarette advertising. [12] [13] [14] For instance, in the USA, where cigarette advertising at POS is common and cigarette displays are allowed, we observed considerably higher reported cigarette advertising exposure at POS (52.1%) than each of the other countries (10.5%-18.5%). Our study suggests a successful implementation of the POS ban in EN, given that 87% of smokers in UK reported exposure to cigarette display and advertising at POS in 2010 and POS display was banned in all shops in EN as of April 2015, 14 whereas less than 15% of respondents in EN reported cigarette advertising at POS in our study. Yet, given that cigarette advertising exposure was most common at POS in all countries, future research should identify loopholes in current regulations to remove them; for instance, the POS display bans do not apply to smoking-related products such as rolling papers and lighters in EN.
We also found that reported exposure to price offers for cigarettes was higher in USA (34.0%) where price offers were allowed, compared with CA (7.8%) and EN (3.6%) where price offers were banned. Compared with USA (34%), exposure to price offers was much lower in AU (8.2%), where POS price offers appear primarily limited to price boards. However, among those exposed, the proportion of those purchasing at special price was highest in AU (64.9% vs 52.3%-31.0% in the other countries). This higher utilisation rate among those exposed to special price offers in AU likely reflects that price boards were being directly used by some smokers to find less-expensive brands in a response to the ongoing, substantial increases in cigarette taxes and prices in AU, 7 suggesting that price offers in AU should be restricted to increase the impact of tax policy.
Again, not unexpectedly, we found that exposure to vaping advertising at POS was higher in EN (49.3%) and USA (45.9%) where vaping advertising is permitted at POS, compared with AU (6.4%) and CA (32.5%) where sales and marketing of NVPs were banned at the time of data collection. The relatively higher exposure to vaping product advertising at POS in CA than AU confirms results from a preliminary report that NVPs were still available in CA at the time of the survey despite the sales ban due to weak enforcement. 10 22 The finding of high exposure to vaping product advertising at POS in EN is also consistent with prior research reporting high levels of NVP advertising at POS in EN after cigarette POS displays were banned and tobacco companies began investing in NVPs. 23 Our findings suggest that vaping advertising efforts in EN may be concentrated on permitted media, such as POS, reflecting bans on NVP ads through company or retailer websites and emails or text messages implemented in 2016. For instance, compared with USA, reported exposure to vaping ads at POS was higher in EN, whereas there was no difference in reported exposure to vaping ads in email or text messages between EN and USA.
Our results suggest the difficulty in enforcing bans on online NVP marketing. Despite a complete ban on the sale and marketing of NVPs, prevalence of exposure to vaping product advertising AOR, Adjusted OR.
Table 4
Continued on websites or social media in CA (15%) was similar to USA (12%), which had virtually no restriction on online marketing. Exposure to vaping product advertising on websites/social media was highest in EN (18%), where online NVP advertising (but not social media advertising or online sales) was banned 2 months before data collection. 11 Given that online NVP advertising may include misleading information 24 and may expose minors to this content, 25 policies should aim to limit misleading online advertising.
Our paper can help inform discussions around whether NVPs are a viable substitute for cigarettes. As expected, compared with exclusive smokers, exclusive vapers and concurrent users were more likely to report vaping ad exposure; however, concurrent users also were more likely than exclusive smokers to report exposure to cigarette ads through any channel. This may be because cigarette advertising is present in stores that sell vaping products, which may impede complete switching to vaping products. However, our cross-sectional results are also subject to selection bias because consumers are likely to be exposed to ads at the places where they purchase their products. 22 To better illuminate these issues, longitudinal studies should integrate product purchase locations and trajectories of concurrent and exclusive product use.
This study has several limitations. First, our analysis is cross-sectional, limiting our ability to assess the temporality of the relationship between marketing exposure and smoking or vaping status. However, the cross-country comparisons provide meaningful information on the patterns of differences across regulatory environments. Second, our self-report measures may not accurately reflect real-world exposure. We also did not assess the frequency of exposure. However, our measures involved a shorter time frame (1 month) than Wadsworth et al's research to minimise recall bias. 26 Future studies using more objective measures of exposure can confirm our findings. Third, the US Food and Drug Administration expanded its regulatory authorities to include NVPs in the May 2016 final deeming rule. As a result, a ban on free distribution of NVPs became effective during our data collection in August 2016. Moreover, the 2009 Tobacco Control Act expanded the ability of states and localities to regulate tobacco marketing and certain cigarette and NVP marketing/sales restrictions in the USA vary by states. Future research should therefore examine the effect of free distribution ban or the variation in local policies. Lastly, the outcomes in relation to price offers for cigarettes should be interpreted with caution, especially when comparing them with vaping products, given that the measure did not distinguish between FM and RYO cigarettes, for which price promotion strategies may differ.
Our study examined exposure to both cigarette and vaping product marketing across countries with different legislative environments among exclusive smokers, exclusive vapers and concurrent users of NVPs and cigarettes to determine how these environments and product use appeared to shape patterns of advertising exposure. Overall, our analyses indicate that cigarette marketing exposure is highest in USA and respondents in AU appear particularly likely to use price offers. Compared with USA, which had no channel-specific ad bans, respondents in CA that completely banned sales and marketing of NVPs at the time of the survey reported lower exposure to advertising at POS but reported similar ad exposure from online channels. Compared with exclusive smokers, exclusive vapers and concurrent users were more likely to report vaping ad exposures. Our findings highlight the need for restricting price offers in AU, the difficulty of regulating online NVP advertising and the possibility Research paper Table 5 Continued that vaping ads influence vaping product use among exclusive smokers.
What this paper adds
What is already known on this subject ► In Australia, which bans cigarette advertising to point of sale, including cigarette displays, but continues to allow large price boards, exposure to price offers has been associated with continued smoking among smokers. ► The strictness of country-level marketing restrictions on nicotine vaping products is generally associated with selfreported exposure to vaping product marketing across channels.
What important gaps in knowledge exist on this topic ► No study has examined cross-country differences in use of price offers. ► No study has examined cross-country differences in past-month self-reported exposure to vaping product advertisements among both smokers and vapers after England banned vaping product advertising through company or retailer websites and emails or text messages.
What this paper add ► The use of price offers among respondents who were exposed to price offers was higher in Australia (64.9%) than USA (52.3%), suggesting that smokers in Australia are particularly likely to use price offers, likely due to high cigarette taxes. ► Exposure to vaping product advertisements on websites or social media does not follow country-specific policies, which suggests difficulties enforcing online marketing bans.
